Recombinant Human FCGR2A(R167) protein, C-His Tag
Product Description
Cat
IMP-653
Official Symbol
FCGR2A
Product Overview
Recombinant Human FCGR2A protein(Accession # P12318-1 (R167) )(Ala 36-Ile 218), fused to C-His Tag, was expressed in HEK293.
Expression System
HEK293
Species
Human
Tag
C-His Tag
Form
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.
Molecular Mass
The protein has a calculated MW of 21.6 kDa. The protein migrates as 25-35 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Protein length
Ala 36-Ile 218
Endotoxin
Less than 1.0 EU per μg by the LAL method.
Purity
>95% as determined by SDS-PAGE.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
Reconstitution
It is recommended that sterile water be added to the vial to prepare a stock solution of 0.2 ug/ul. Centrifuge the vial at 4°C before opening to recover the entire contents.
SDS-PAGE
SDS-PAGE

Bioactivity-BLI 1

Loaded Rituximab on Protein A Biosensor, can bind Human CD32a (R167), His Tag (BLI verified) with an affinity constant of 1.5 μM as determined in BLI assay.

Bioactivity-BLI 2
Bioactivity-BLI

Loaded Human CD32a (R167), His Tag (BLI verified) on HIS1K Biosensor, can bind Rituximab with an affinity constant of 1.4 μM as determined in BLI assay.

Bioactivity-SPR 1
Bioactivity-SPR

Immobilized Human CD32a (R167), His Tag (BLI verified) on CM5 Chip via anti-His antibody, can bind Rituximab with an affinity constant of 3.12 μM as determined in a SPR assay.

Data Sheet MSDS
For research or industrial raw materials, not for personal medical use!

Online Inquiry
Contact Info